G1H Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - G1 Therapeutics Inc

Watchlist Manager

Watchlist

Price: 6.345 EUR Market Closed

Market Cap: €331.7m

G	G1 Therapeutics Inc F:G1H	US
F	Ford Motor Co DUS:FMC1	US
	Iss A/S OTC:ISFFF	DK
	LEG Immobilien SE OTC:LEGIF	DE
	Axway Software SA F:1XV	FR
	Cooper Companies Inc NASDAQ:COO	US

Profitability Summary

G1 Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

92%

Declining Gross Margin

94% > 89%

Negative Operating Margin

-65%

Negative 3Y Average Operating Margin

-59%

Operating Margin is Increasing

-75% > -65%

Negative Net Margin

-77%

Negative 3Y Average Net Margin

-70%

Net Margin is Increasing

-87% > -77%

Negative Free Cash Flow Margin

-65%

Negative 3Y Average Free Cash Flow Margin

-56%

Free Cash Flow Margin is Increasing

-75% > -65%

Negative ROE

-109%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-137%

ROIC is Increasing

-194% > -112%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

92%

Declining Gross Margin

94% > 89%

Negative Operating Margin

-65%

Negative 3Y Average Operating Margin

-59%

Operating Margin is Increasing

-75% > -65%